Next Article in Journal
Mesoporous Silica-Based Membranes in Transdermal Drug Delivery: The Role of Drug Loss in the Skin
Next Article in Special Issue
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma
Previous Article in Journal
Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(8), 994; https://doi.org/10.3390/pharmaceutics16080994
Action Date Notes Link
article pdf uploaded. 26 July 2024 16:01 CEST Version of Record https://www.mdpi.com/1999-4923/16/8/994/pdf-vor
article supplementary file uploaded. 26 July 2024 16:01 CEST - https://www.mdpi.com/1999-4923/16/8/994#supplementary
article xml file uploaded 29 July 2024 12:39 CEST Original file -
article xml uploaded. 29 July 2024 12:39 CEST Update https://www.mdpi.com/1999-4923/16/8/994/xml
article pdf uploaded. 29 July 2024 12:39 CEST Updated version of record https://www.mdpi.com/1999-4923/16/8/994/pdf
article html file updated 29 July 2024 12:40 CEST Original file https://www.mdpi.com/1999-4923/16/8/994/html
Back to TopTop